Cost-effectiveness of Novel Colorectal Neoplasia Screening Tests
Clinical Gastroenterology and Hepatology · 2026-08 · 24 (8) · 2325-2326
DOI: 10.1016/j.cgh.2025.10.033 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-08. Verfasst von Paul J Limburg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Exact Sciences Corporation, Madison, Wisconsin. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Exact Sciences Corporation, Madison, Wisconsin.
- Division of General Medicine, University of Michigan, Ann Arbor, Michigan.
- Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Zitieren
APA
Limburg, P. J., Fendrick, A. M., Imperiale, T. F., & Kisiel, J. B. (2026). Cost-effectiveness of Novel Colorectal Neoplasia Screening Tests. Clinical Gastroenterology and Hepatology, 24(8), 2325-2326. https://doi.org/10.1016/j.cgh.2025.10.033
Vancouver
Limburg PJ, Fendrick AM, Imperiale TF, Kisiel JB. Cost-effectiveness of Novel Colorectal Neoplasia Screening Tests. Clinical Gastroenterology and Hepatology. 2026;24(8):2325-2326. doi:10.1016/j.cgh.2025.10.033
BibTeX
@article{Limburg2026,
author = {Limburg, Paul J and Fendrick, A Mark and Imperiale, Thomas F and Kisiel, John B},
title = {Cost-effectiveness of Novel Colorectal Neoplasia Screening Tests},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {8},
pages = {2325--2326},
doi = {10.1016/j.cgh.2025.10.033}
}
EUVIMED